Sen Xu

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

Biotechnology progress

Biotechnology and bioengineering

mAbs

Bristol Myers Squibb

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Bristol Myers Squibb

United States

Group Leader :: Biologics Development

Merck & Co., Inc.

United States

Principal Scientist :: Biologics Process Research & Development

Publications

Yixiao Zhang, Sri Madabhushi, Tiffany Tang, Hassan Raza, David J Busch, Xi Zhao, James Ormes, Sen Xu, Joseph Moroney, Rubin Jiang, Henry Lin, Ren Liu
Contributions of Chinese hamster ovary cell derived extracellular vesicles and other cellular materials to hollow fiber filter fouling during perfusion manufacturing of monoclonal antibodies. Biotechnology and bioengineering 121 (5) (2024)
Yixiao Zhang, Sri Madabhushi, Tiffany Tang, Hassan Raza, David J Busch, Xi Zhao, James Ormes, Sen Xu, Joseph Moroney, Rubin Jiang, Henry Lin, Ren Liu
Contributions of Chinese hamster ovary cell derived extracellular vesicles and other cellular materials to hollow fiber filter fouling during perfusion manufacturing of monoclonal antibodies. Biotechnology and bioengineering (2024)
Yixiao Zhang, Sri Madabhushi, Tiffany Tang, Hassan Raza, David J Busch, Xi Zhao, James Ormes, Sen Xu, Joseph Moroney, Rubin Jiang, Henry Lin, Ren Liu
Contributions of Chinese hamster ovary cell derived extracellular vesicles and other cellular materials to hollow fiber filter fouling during perfusion manufacturing of monoclonal antibodies. Biotechnology and bioengineering (2024)
Yixiao Zhang, Sri Madabhushi, Tiffany Tang, Hassan Raza, David J Busch, Xi Zhao, James Ormes, Sen Xu, Joseph Moroney, Rubin Jiang, Henry Lin, Ren Liu
Contributions of Chinese hamster ovary cell derived extracellular vesicles and other cellular materials to hollow fiber filter fouling during perfusion manufacturing of monoclonal antibodies. Biotechnology and bioengineering 121 (5) (2024)
Parimala Bolisetty, Gabi Tremml, Sen Xu, Anurag Khetan
Enabling speed to clinic for monoclonal antibody programs using a pool of clones for IND-enabling toxicity studies. mAbs 12 (1) (2021)
Xiaolin Zhang, Rubin Jiang, Henry Lin, Sen Xu
Feeding tricarboxylic acid cycle intermediates improves lactate consumption and antibody production in Chinese hamster ovary cell cultures. Biotechnology progress 36 (4) (2020)
Sen Xu, Michael Borys, Anurag Khetan, Itzcoatl Pla
Osmolality as a lever to modulate the N-glycolylneuraminicacid (Neu5Gc) level of a recombinant glycoprotein produced in Chinese hamster ovary cells. Biotechnology progress 36 (6) (2020)
Matthew Manahan, Michael Nelson, Jonathan J Cacciatore, Jessica Weng, Sen Xu, Jennifer Pollard
Scale-down model qualification of ambr® 250 high-throughput mini-bioreactor system for two commercial-scale mAb processes. Biotechnology progress 35 (6) (2019)
Sen Xu, Rubin Jiang, Roland Mueller, Nadja Hoesli, Thomas Kretz, John Bowers, Hao Chen
Probing lactate metabolism variations in large-scale bioreactors. Biotechnology progress 34 (3) (2018)
Sri R Madabhushi, John Gavin, Sen Xu, Collette Cutler, Rebecca Chmielowski, William Rayfield, Nihal Tugcu, Hao Chen
Quantitative assessment of environmental impact of biologics manufacturing using process mass intensity analysis. Biotechnology progress 34 (6) (2018)
Linda Hoshan, Rubin Jiang, Joseph Moroney, Ashley Bui, Xiaolin Zhang, Ta-Chun Hang, Sen Xu
Effective bioreactor pH control using only sparging gases. Biotechnology progress 35 (1) (2018)
Sen Xu, Linda Hoshan, Rubin Jiang, Balrina Gupta, Eric Brodean, Kristin O'Neill, T Craig Seamans, John Bowers, Hao Chen
A practical approach in bioreactor scale-up and process transfer using a combination of constant P/V and vvm as the criterion. Biotechnology progress 33 (4) (2017)

Sen Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sen Xu